Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated
Company type	Public
Traded as	Nasdaq: VRTX; Nasdaq-100 component; S&P 500 component;
Industry	Pharmaceuticals; Biotherapeutics;
Founded	1989
Headquarters	Boston, Massachusetts, U.S.
Key people	Reshma Kewalramani (president and CEO); Jeffrey Leiden (chairman); David Altshuler (CSO);
Products	Pharmaceuticals
Revenue	US$11.02 billion (2024)
Operating income	US$−233 million (2024)
Net income	US$−536 million (2024)
Total assets	US$22.53 billion (2024)
Total equity	US$16.41 billion (2024)
Number of employees	6,100 (2024)
Website	vrtx.com
	Footnotes / references;

Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.